PRO-DRUGS OF BETA -LACTAM ANTIBIOTICSFERRES H.1980; CHEM. IND. (LOND.); ISSN 0009-3068; GBR; DA. 1980; NO 11; PP. 435-440; BIBL. 19 REF.Article

ADDITION REACTIONS OF CONJUGATED DOUBLE BONDS. V. STEREOCHEMISTRY OF PYRAZOLINE RING FORMATION FROM ALPHA BETA -UNSATURATED PHENYLHYDRAZONESFERRES H; HAMDAM MS; JACKSON WR et al.1973; J. CHEM. SOC., PERKIN TRANS., 2; G.B.; DA. 1973; NO 7; PP. 936-938; BIBL. 19 REF.Serial Issue

A DIASTEREOSELECTIVE SYNTHESIS OF 4(RS), 6(SR)-MERCAPTOMETHYLMEVALONOLACTONE, A KEY INTERMEDIATE IN THE PREPARATION OF A NEW CLASS OF INHIBITORS OF HMG-COA REDUCTASEFERRES H; HATTON IK; JENNINGS LJA et al.1983; TETRAHEDRON LETTERS; ISSN 0040-4039; GBR; DA. 1983; VOL. 24; NO 35; PP. 3769-3772; BIBL. 13 REF.Article

BETA -LACTAM ANTIBIOTICS. II: STRUCTURE-ACTIVITY RELATIONSHIPS OF 6-(ALPHA -(ALPHA '-UREIDO-ACYLAMINO) ACYLAMINO) PENICILLANIC ACIDSFERRES H; BASKER MJ; BEST DJ et al.1978; J. ANTIBIOT.; JPN; DA. 1978; VOL. 31; NO 10; PP. 1013-1022; BIBL. 11 REF.Article

PREPARATION, HYDROLYSIS, AND ORAL ABSORPTION OF LACTONYL ESTERS OF PENICILLINS.CLAYTON JP; COLE M; ELSON SW et al.1976; J. MEDICIN. CHEM.; U.S.A.; DA. 1976; VOL. 19; NO 12; PP. 1385-1391; BIBL. 14 REF.Article

Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirinFEARS, R; FERRES, H; GREENWOOD, H. C et al.Thrombosis research. 1990, Vol 60, Num 4, pp 259-268, issn 0049-3848, 10 p.Article

Kinetic studies on novel plasminogen activators: demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-276) or urokinase (Ile-159)FEARS, R; DODD, I; FERRES, H et al.Biochemical journal (London. 1906). 1990, Vol 266, Num 3, pp 693-696, issn 0006-2936Article

Decrease in LDL and increase in HDL concentrations in type II hyperlipoproteinaemic patients on low-dose combination therapy of cholestyramine and Complamin^®FEARS, R; FERRES, H; HAACKE, H et al.Atherosclerosis. 1988, Vol 69, Num 2-3, pp 97-101, issn 0021-9150Article

Effects of novel bile salts on cholesterol metabolism in rats and guinea-pigsFEARS, R; BROWN, R; FERRES, H et al.Biochemical pharmacology. 1990, Vol 40, Num 9, pp 2029-2037, issn 0006-2952, 9 p.Article

Slow clearance of acylated, hybrid thrombolytic enzymesROBINSON, J. H; DODD, I; ESMAIL, A et al.Thrombosis and haemostasis. 1988, Vol 59, Num 3, pp 421-425, issn 0340-6245Article

Hyperalphalipoproteinaemic activity of BRL 26314. II: Inhibition of atherosclerosis in rabbitsFEARS, R; ESMAIL, A; WALKER, P et al.Biochemical pharmacology. 1984, Vol 33, Num 2, pp 219-228, issn 0006-2952Article

A comparison of the pharmacokinetic properties of streptokinase and anistreplase in acute myocardial infarctionGEMMILL, J. D; HOGG, K. J; HILLIS, W. S et al.British journal of clinical pharmacology. 1991, Vol 31, Num 2, pp 143-147, issn 0306-5251, 5 p.Article

Cardioprotection and thrombolysis by anistreplase in anesthetized dogsFEUERSTEIN, G. Z; NICHOLS, A. J; VALOCIK, R. E et al.Journal of cardiovascular pharmacology. 1995, Vol 25, Num 4, pp 625-633, issn 0160-2446Article

N-substituted amino acid derivatives with hyperalphalipoproteinaemic activityBAGGALEY, K. H; FEARS, R; FERRES, H et al.European journal of medicinal chemistry. 1988, Vol 23, Num 6, pp 523-531, issn 0223-5234Article